Conference Chairs
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
[/col] [col class="span3"]
Dr. Bruce Bloom
[/col] [col class="span3"]
[/col] [col class="span3"]
Aris Persidis, Ph.D.
[/col] [/row]
Speaking Faculty
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
David Hayes, Ph.D.
- Director, Translational Research Science
- AstraZeneca
[/col] [col class="span3"]
-
Bryn Williams Jones
- Director of Exploratory Research
- Benevolent AI
[/col][col class="span3"]
-
W. Scott Spangler
- Chief Data Scientist, Distinguished Engineer
- IBM Watson Health
[/col][col class="span3"]
-
Stephen Wong, Ph.D.
- Chair and Professor, Systems Medicine
- Houston Methodist
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Clare Thibodeaux, Ph.D.
- Director of Scientific Affairs
- Cures Within Reach
[/col] [col class="span3"]
-
Robert Lavieri, Ph.D.
- Project Manager, Vanderbilt Institute for Clinical and Translational Research
- Vanderbilt University Medical Center
[/col] [col class="span3"]
-
Hermann Mucke, Ph.D.
- Principal
- H.M. Pharma Consultancy
[/col] [col class="span3"]
-
Paul Spagnuolo, Ph.D.
- Associate Professor, Department of Food Science
- University of Guelph
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Steven Corsello, MD
- Postdoctoral Scholar, Broad Institute
- Instructor in Medicine, Dana-Farber Cancer Institute
[/col] [col class="span3"]
-
Ana Casas Guijarro, Ph.D.
- Department of Pharmacology and Personalised Medicine
- Maastricht University
[/col] [col class="span3"]
-
Agustin J. Lopez Marquez
- Vice President, Business Development and Marketing
- nference, Qrativ
[/col] [col class="span3"]
-
Kas Subramanian, Ph.D.
- Vice President & Head of Bioinformatics
- Syngene International
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Lou DeGennaro, Ph.D.
- President and CEO
- The Leukemia and Lymphoma Society
[/col] [col class="span3"]
-
Vijay Shahani, Ph.D.
- Senior Solution Scientist
- CyclicaRx
[/col] [col class="span3"]
-
Martin Zeidler, Ph.D.
- Reader, Cellular Signaling, Department of Biomedical Science
- University of Sheffield
[/col] [col class="span3"]
-
Scott J. Weir, Pharm.D., Ph.D.
- Dir., Institute for Advancing Medical Innovation, Assoc. Dir., Translational Research, Univ. of Kansas Cancer Ctr., Prof., Dept. of Pharmacology, Toxicology & Therapeutics
- University of Kansas Medical Center
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
David McKie
- VP of Marketing Solutions
- Medidata Solutions
[/col] [col class="span3"]
-
Fred Marin, Pharm.D.
- Co-Founder and CEO
- OP2 Drugs SAS
[/col] [col class="span3"]
-
Michale Bouskila-Chubb, Ph.D., MBA
- Head of Business Development
- Healx
[/col] [/row]